De Novo device
GI Genius System 100 and GI Genius System 200
Cosmo Artificial Intelligence - Ai, Ltd. · Gastrointesinal Lesion Software Detection System (QNP, Class II) · First FDA decision Apr 9, 2021, newest May 19, 2023Colorectal cancer and polyps
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
27
Naming "GI Genius"
MAUDE reports
0
Brand "GI Genius", since 2015
PubMed studies
46
Mentioning "GI Genius"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GI Genius System 100 and GI Genius System 200
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K231143 · Decided May 19, 2023 · 28 days after receipt
Device type: Gastrointesinal Lesion Software Detection System (QNP) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "GI Genius", any status and sponsor, newest update first.
- Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp HistologyPivotal-lookingRecruiting
Istituto Clinico HumanitasAcademic, hospital or other
NCT06041945 · 1,800 participants (planned) · Start Sep 21, 2023 · Primary completion Sep 1, 2027
Device: Standard, high-definition colonoscopy with the use of CADe assistance; Standard, high-definition colonoscopy with the use of CADe/CADx assistance, no leave-in-situ and 1 more · For: Colonic Neoplasms
Sites: Rozzano, Italy · 2 sites in all
26 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GI Genius", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QNP
2 reports: 2 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "GI Genius"[tiab]. The summary above synthesizes these.
- Polyp detection with colonoscopy assisted by the GI Genius artificial intelligence endoscopy module compared with standard colonoscopy in routine colonoscopy practice (COLO-DETECT): a multicentre, open-label, parallel-arm, pragmatic randomised controlled trial.
Seager A, Sharp L, Neilson LJ, et al. · Lancet Gastroenterol Hepatol · 2024Multicenter Study, Pragmatic Clinical Trial
- GI genius endoscopy module: a clinical profile.
Savino A, Rondonotti E, Rocchetto S, et al. · Expert Rev Med Devices · 2024Review
- Artificial intelligence and colonoscopy experience: lessons from two randomised trials.
Repici A, Spadaccini M, Antonelli G, et al. · Gut · 2022Randomized Controlled Trial, Equivalence Trial
- Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy.
Hassan C, Povero M, Pradelli L, et al. · Endosc Int Open · 2023
- Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial.
Repici A, Badalamenti M, Maselli R, et al. · Gastroenterology · 2020Multicenter Study, Randomized Controlled Trial
- A video based benchmark data set (ENDOTEST) to evaluate computer-aided polyp detection systems.
Fitting D, Krenzer A, Troya J, et al. · Scand J Gastroenterol · 2022Research Support, Non-U.S. Gov't
- Artificial Intelligence-Aided Colonoscopy Does Not Increase Adenoma Detection Rate in Routine Clinical Practice.
Levy I, Bruckmayer L, Klang E, et al. · Am J Gastroenterol · 2022Research Support, Non-U.S. Gov't
- An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial.
Ortiz O, Daca-Alvarez M, Rivero-Sanchez L, et al. · Lancet Gastroenterol Hepatol · 2024Randomized Controlled Trial, Multicenter Study
- Discovering the first US FDA-approved computer-aided polyp detection system.
Spadaccini M, Marco A, Franchellucci G, et al. · Future Oncol · 2022Review
- Direct comparison of multiple computer-aided polyp detection systems.
Troya J, Sudarevic B, Krenzer A, et al. · Endoscopy · 2024
- Cost-effectiveness of Artificial Intelligence-Aided Colonoscopy for Adenoma Detection in Colon Cancer Screening.
Barkun AN, von Renteln D, Sadri H · J Can Assoc Gastroenterol · 2023
- Long-term impact of artificial intelligence on colorectal adenoma detection in high-risk colonoscopy.
Chow KW, Bell MT, Cumpian N, et al. · World J Gastrointest Endosc · 2024
Other devices of this type
Also filed under product code QNP.
- SKOUT® systemIterative Scopes, Inc. · 510(k) 2024
- CaddieOdin Medical Limited · 510(k) 2026
- GI Genius Module 300 (GGM300-US)Cosmo Artificial Intelligence - Ai, Ltd. · 510(k) 2026
- Magentiq-Colo (Me-Apds)Magentiq Eye, Ltd. · 510(k) 2026
- EW10-EC02 Endoscopy Support ProgramFujifilm Corporation · 510(k) 2026
- SKOUT systemIterative Health · 510(k) 2025
- CAD - Lower GI (EC07-01)Xiamen Inno Medical Technology Co., Ltd. · 510(k) 2026
- Me-ApdsMagentiq Eye, Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.